Profile data is unavailable for this security.
About the company
Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
- Revenue in SEK (TTM)75.12m
- Net income in SEK-24.17m
- Incorporated1985
- Employees38.00
- LocationOrtivus ABSvardvagen 19DANDERYD 182 33SwedenSWE
- Phone+46 84464500
- Fax+46 84464519
- Websitehttps://www.ortivus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PMD Device Solutions AB | 51.91m | -43.42m | 44.45m | 37.00 | 0.3239 | -- | -- | 0.8563 | 5.06 | 5.06 | 3.54 | -5.52 | 0.8624 | -- | 4.47 | -- | -72.13 | -- | -- | -- | 82.86 | -- | -83.64 | -- | 0.1121 | -1.88 | -- | -- | -- | -- | -- | -- | -- | -- |
| iZafe Group AB | 6.29m | -31.99m | 58.30m | 7.00 | -- | 3.74 | -- | 9.27 | -0.1319 | -0.1319 | 0.0259 | 0.0567 | 0.1602 | 3.25 | 12.26 | 898,285.70 | -81.49 | -52.17 | -100.43 | -69.40 | -116.33 | -198.20 | -508.73 | -487.50 | 0.4406 | -43.46 | 0.3159 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
| Clinical Laserthermia Systems AB | 18.63m | -64.20m | 70.12m | 7.00 | -- | 0.9258 | -- | 3.76 | -7.93 | -7.93 | 2.05 | 4.39 | 0.265 | 7.62 | 5.22 | -- | -92.16 | -123.49 | -103.14 | -312.95 | -175.42 | -1,084.16 | -347.76 | -1,625.03 | 2.39 | -11.71 | 0.0077 | -- | 31.99 | 35.55 | -12.92 | -- | 18.26 | -- |
| Ortivus AB | 75.12m | -24.17m | 74.39m | 38.00 | -- | 10.15 | -- | 0.9902 | -0.5455 | -0.5455 | 1.70 | 0.1601 | 1.08 | 4.41 | 8.15 | 1,878,050.00 | -34.67 | -2.41 | -79.30 | -4.63 | 32.08 | 42.46 | -32.17 | -1.77 | 0.4501 | -54.17 | 0.7367 | -- | -19.55 | 10.00 | -409.66 | -- | 67.43 | -- |
| Dignitana AB | 86.49m | -25.27m | 86.99m | 29.00 | -- | 8.89 | -- | 1.01 | -0.3268 | -0.3268 | 1.13 | 0.1215 | 1.74 | 2.76 | 15.19 | 3,203,482.00 | -50.91 | -42.21 | -122.38 | -68.91 | 69.56 | 66.09 | -29.22 | -57.29 | 0.5202 | -9.97 | 0.609 | -- | 17.90 | 20.59 | 22.52 | -- | -15.31 | -- |
| Glycorex Transplantation AB (publ) | 31.03m | -27.83m | 87.53m | 15.00 | -- | 2.39 | -- | 2.82 | -0.3768 | -0.3768 | 0.4201 | 0.5186 | 0.412 | 0.8382 | 3.69 | 1,348,913.00 | -36.96 | -11.30 | -46.32 | -13.17 | 82.91 | 91.60 | -89.70 | -33.24 | 1.09 | -71.86 | 0.2084 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
| SciBase Holding AB (publ) | 25.71m | -59.24m | 92.65m | 27.00 | -- | 1.75 | -- | 3.60 | -0.4495 | -0.4495 | 0.1884 | 0.2409 | 0.299 | 0.7328 | 4.04 | 952,222.30 | -68.89 | -68.63 | -89.67 | -87.77 | 70.02 | 61.28 | -230.41 | -300.20 | 3.11 | -62.08 | 0.00 | -- | 29.93 | 27.50 | -28.75 | -- | 5.15 | -- |
| ScandiDos AB | 61.35m | -9.67m | 94.64m | 26.00 | -- | 2.17 | -- | 1.54 | -0.2068 | -0.2068 | 1.26 | 0.766 | 0.8184 | 1.31 | 6.88 | 1,978,871.00 | -12.90 | -12.60 | -23.54 | -21.76 | 50.39 | 51.58 | -15.76 | -15.37 | 0.9476 | -6.36 | 0.00 | -- | -1.82 | 4.36 | -60.62 | -- | -19.29 | -- |
| Kontigo Care AB | 29.65m | 1.75m | 94.86m | 10.00 | 42.66 | 1.95 | 17.89 | 3.20 | 0.0694 | 0.0694 | 1.11 | 1.51 | 0.6241 | -- | 8.03 | -- | 3.68 | -0.4214 | 5.03 | -0.6195 | 69.93 | 66.31 | 5.89 | -0.5205 | -- | 10.00 | 0.0569 | -- | 1.80 | 16.95 | -92.68 | -- | 44.94 | -- |
| Observe Medical ASA | -98.44bn | -98.44bn | 95.57m | 5.00 | -- | 0.6194 | -- | -- | -- | -- | -- | 0.5635 | -- | -- | -- | -- | -- | -32.60 | -- | -49.80 | -- | 32.83 | -- | -256.25 | 0.193 | -- | 0.3425 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
| Luxbright AB | 4.20m | -22.23m | 105.36m | 10.00 | -- | 3.54 | -- | 25.07 | -0.24 | -0.24 | 0.0454 | 0.2641 | 0.104 | -- | 4.14 | 420,270.00 | -55.02 | -61.39 | -62.23 | -70.36 | -134.43 | -577.85 | -528.90 | -2,529.11 | 0.7743 | -4,539.47 | 0.0084 | -- | 55.58 | -- | -20.07 | -- | -- | -- |
| Immunovia AB (publ) | 885.00k | -116.12m | 106.92m | 10.00 | -- | 2.91 | -- | 120.81 | -1.30 | -1.30 | 0.0099 | 0.2162 | 0.0071 | -- | 14.39 | 80,454.55 | -93.50 | -41.33 | -133.56 | -44.24 | -6,702.03 | -7,553.76 | -13,120.79 | -20,879.29 | -- | 2.48 | 0.3064 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Episurf Medical AB | 12.80m | -79.70m | 107.16m | 26.00 | -- | 1.06 | -- | 8.37 | -0.2072 | -0.2072 | 0.0301 | 0.1558 | 0.1059 | -- | 5.57 | 457,142.80 | -66.09 | -47.46 | -75.45 | -52.01 | -- | -- | -624.22 | -1,019.29 | 6.17 | -- | 0.0296 | -- | 53.62 | 19.78 | -22.64 | -- | -0.4158 | -- |
| Vo2 Cap Holding AB (publ) | 348.03m | -55.15m | 108.36m | 94.00 | -- | 0.6021 | -- | 0.3114 | -0.9759 | -0.9759 | 6.46 | 3.16 | 0.7992 | -- | 8.21 | 3,378,952.00 | -12.66 | -0.2564 | -17.29 | -0.3839 | 35.78 | 23.36 | -15.84 | -0.2409 | -- | -6.95 | 0.1429 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
| Phase Holographic Imaging PHI AB | 9.12m | -21.81m | 109.02m | 14.00 | -- | -- | -- | 11.95 | -0.8695 | -0.8695 | 0.3634 | -0.0273 | 0.2373 | 0.6598 | 1.18 | 651,571.40 | -56.73 | -62.04 | -88.25 | -79.16 | 71.06 | 63.16 | -239.04 | -328.50 | 0.1916 | -5.61 | 1.04 | -- | 6.16 | 17.96 | 12.98 | -- | 22.76 | -- |
| Iconovo AB | 2.92m | -40.21m | 109.52m | 28.00 | -- | 0.7354 | -- | 37.55 | -2.74 | -2.74 | 0.196 | 7.02 | 0.0215 | -- | 1.14 | 100,561.70 | -29.61 | -25.43 | -33.16 | -28.24 | 635.97 | 134.57 | -1,378.66 | -215.16 | -- | -1,179.07 | 0.0668 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
Data as of Nov 13 2024. Currency figures normalised to Ortivus AB's reporting currency: Swedish Krona SEK
5.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Seligson & Co. Rahastoyhti� Oyjas of 31 Oct 2024 | 1.60m | 3.74% |
| Handelsbanken Fonder ABas of 30 Sep 2024 | 251.00k | 0.59% |
| FCG Fonder ABas of 30 Sep 2024 | 168.26k | 0.40% |
| SEB Investment Management ABas of 30 Sep 2024 | 112.36k | 0.26% |
| Skandia Investment Management ABas of 30 Aug 2024 | 67.45k | 0.16% |
| Evli Fund Management Co. Ltd.as of 30 Aug 2024 | 34.32k | 0.08% |
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
